Vivalyx Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2.6M

  • Investors
  • 20

Vivalyx General Information

Description

Operator of a patented organ preservation company intended to improve the success of organ transplantation. The company offers a cell-free and oxygen carrier-free perfusate for normothermic machine perfusion and cold storage, enabling medical professionals to reduce biliary complications and improve renal function in transplanted organs without the need for blood-based resources.

Contact Information

Website
www.vivalyx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Gottfried-Hagen-Straße 60-62
  • 51105 Cologne
  • Germany
+49 0241
Primary Industry
Medical Supplies
Other Industries
Biotechnology
Corporate Office
  • Gottfried-Hagen-Straße 60-62
  • 51105 Cologne
  • Germany
+49 0241

Vivalyx Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vivalyx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 19-Feb-2025 $2.6M Completed Generating Revenue
7. Early Stage VC 01-Jan-2025 Completed Generating Revenue
6. Seed Round 30-Apr-2024 Completed Generating Revenue
5. Seed Round 15-Jun-2023 Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
2. Accelerator/Incubator Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view Vivalyx’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Vivalyx Patents

Vivalyx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026073910-A1 Device for transporting an organ or tissue Pending 02-Oct-2024
WO-2026073913-A1 Device for transporting an organ or tissue Pending 02-Oct-2024
CA-2981588-A1 Organ preservation composition Active 03-Apr-2015
EP-3277083-A1 Organ preservation composition Active 03-Apr-2015
US-10874098-B2 Organ preservation composition Active 03-Apr-2015 A01N1/126
To view Vivalyx’s complete patent history, request access »

Vivalyx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vivalyx Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Accelerator/Incubator Minority
Deepbright Ventures Venture Capital Minority
Nextgen Ventures Venture Capital Minority
Angel (individual) Minority
Angel Invest Venture Capital Minority
You’re viewing 5 of 20 investors. Get the full list »

Vivalyx FAQs

  • When was Vivalyx founded?

    Vivalyx was founded in 2022.

  • Where is Vivalyx headquartered?

    Vivalyx is headquartered in Cologne, Germany.

  • What is the size of Vivalyx?

    Vivalyx has 9 total employees.

  • What industry is Vivalyx in?

    Vivalyx’s primary industry is Medical Supplies.

  • Is Vivalyx a private or public company?

    Vivalyx is a Private company.

  • What is Vivalyx’s current revenue?

    The current revenue for Vivalyx is .

  • How much funding has Vivalyx raised over time?

    Vivalyx has raised $5.79M.

  • Who are Vivalyx’s investors?

    European Innovation Council, Deepbright Ventures, Nextgen Ventures, , and Angel Invest are 5 of 20 investors who have invested in Vivalyx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process